reports
America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2025 Results
America’s Car-Mart Reports Fourth Quarter and Fiscal Year 2025 Results ROGERS, Ark, June 12, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today reported financial results for the fourth quarter and full year ended April 30, 2025. Fourth Quarter Key Highlights (FY’25 Q4 vs. FY’24 Q4, unless otherwise noted) Total revenue was $370.2 million, up 1.5%Sales volumes increased 2.6% to 15,649 unitsInterest income increased $2.4 million, or 4.2%Total collections increased 2.1% to $191.1 millionGross margin percentage increased 90 basis poi...
- Jonathan Moreland
PLUG PLUG POWER INC.
PBF PBF ENERGY INC. CLASS A
BRKR BRUKER CORPORATION
UEIC UNIVERSAL ELECTRONICS INC.
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
BRT BRT APARTMENTS
QTRX QUANTERIX CORPORATION
RFL RAFAEL HOLDINGS CL B
BBDC BARINGS BDC INC.
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
DLHC DALEIGH HOLDINGS CORP
RNXT RENOVORX INC
America’s Car-Mart, Inc. Schedules Fourth Quarter Fiscal Year 2025 Res...
America’s Car-Mart, Inc. Schedules Fourth Quarter Fiscal Year 2025 Results and Conference Call ROGERS, Ark., June 05, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2025 fourth quarter financial results on Thursday, June 12, 2025, before the market opens. A webcast and conference call will be held that same day at 9:00 a.m. ET to review the Company’s results. Participants may access the conference call via webcast using this link: . To participate via telephone, please register in advance using this . Upon registration, all telepho...
BRT Apartments Corp. Announces Quarterly Dividend
BRT Apartments Corp. Announces Quarterly Dividend GREAT NECK, N.Y., June 04, 2025 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE: BRT) announced today that its Board of Directors declared a quarterly dividend of $0.25 per share. The dividend is payable on July 9, 2025, to stockholders of record at the close of business on June 25, 2025. BRT is a real estate investment trust that owns, operates and, to a lesser extent, holds interests in joint ventures that own multi-family properties. As of March 31, 2025, BRT owns or has interests in 29 multi-family properties with 7,947 units in 11 sta...
- Jonathan Moreland
CTBI COMMUNITY TRUST BANCORP INC.
BUSE FIRST BUSEY CORPORATION
VFF VILLAGE FARMS INTERNATIONAL IN
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
CIA CITIZENS INC. CL A
GBLI GLOBAL INDEMNITY PLC
SVRA SAVARA
BRT BRT APARTMENTS
TDW TIDEWATER INC
AMPY AMPLIFY ENERGY
ADV ADVANTAGE SOLUTIONS INC (A)
SMMT SUMMIT THERAPEUTICS INC
BHRB BURKE & HERBERT BANK & TR/VA
DPG DUFF & PHELPS GLOBAL UTIL INCOME FD
GENK GEN RESTAURANT GROUP INC
NKGN NKGEN BIOTECH INC
SLS SELLAS LIFE SCIENCES GROUP INC
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TRS TRIMAS CORPORATION
TLYS TILLYS
PENN PENN NATIONAL GAMING INC.
PEB PEBBLEBROOK HOTEL TRUST
MCY MERCURY GENERAL CORPORATION
LTRX LANTRONIX INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
FLO FLOWERS FOODS INC.
BUSE FIRST BUSEY CORPORATION
VFF VILLAGE FARMS INTERNATIONAL IN
EXP EAGLE MATERIALS INC.
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
BDL FLANIGAN'S ENTERPRISES INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
BXC BLUELINX HOLDINGS
HAIN THE HAIN CELESTIAL GROUP
GPMT INC.
NHF GRANITE POINT MORTGAGE TRUST INC.
BCBP NEXPOINT CREDIT STRATEGIES FUN
BRT BCB BANCORP INC.
PMTS BRT APARTMENTS
MPB CPI CARD GROUP
NWPP MID PENN BANCORP INC.
RFL NEW PEOPLES BANKSHARES INC.
KKR RAFAEL HOLDINGS CL B
REZI KKR & CO. INC.
LBSRD RESIDEO TECHNOLOGIES
XRX INC.
VLA LIBERTY STAR URANIUM & METALS
INNV XEROX HOLDINGS CORPORATION
ALIT ARBOR METALS
TCRX INNOVAGE HOLDING
UDMY ALIGHT
BHRB INC. / DELAWARE
OPAL FIRST EAGLE ALTERNATIVE CAPITAL BDC INC
PRME UDEMY INC
VFC BURKE & HERBERT BANK & TR/VA
UHG OPAL FUELS INC
HYLN PRIME MEDICINE INC
NCDL VF CORPORATION
PROP UNITED HOMES GROUP INC
FIP HYLIION HOLDINGS CORP.
TXO NUVEEN CHURCHILL DIRECT LENDING CORP
NEO PRAIRIE OPERATING CO.
JEQ FTAI INFRASTRUCTURE INC
MORNINGSTAR PARTNERS
L.P.
NEO CORPORATE PUBLIC COMPANY LIMITED
THE JAPAN EQUITY FUND
INC.
- Jonathan Moreland
SON SONOCO PRODUCTS COMPANY
NCR NCR CORPORATION
UNH UNITEDHEALTH GROUP INCORPORATED
RYAM RAYONIER ADVANCED MATERIALS INC
PLUG PLUG POWER INC.
PENN PENN NATIONAL GAMING INC.
PEB PEBBLEBROOK HOTEL TRUST
OEC ORION ENGINEERED CARBONS SA
MTX MINERALS TECHNOLOGIES INC.
MTDR MATADOR RESOURCES COMPANY
MO ALTRIA GROUP INC
LGND LIGAND PHARMACEUTICALS INCORPORATED
JRVR JAMES RIVER GROUP HOLDINGS LTD
HUN HUNTSMAN CORPORATION
HUM HUMANA INC.
ASB ASSOCIATED BANC-CORP
NEWT NEWTEK BUSINESS SERVICES INC.
RLMD RELMADA THERAPEUTICS
VFF VILLAGE FARMS INTERNATIONAL IN
HTLD HEARTLAND EXPRESS INC.
VSH VISHAY INTERTECHNOLOGY INC.
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
BXC BLUELINX HOLDINGS
GBLI GLOBAL INDEMNITY PLC
AMBC AMBAC FINANCIAL GROUP INC.
FCNCA FIRST CITIZENS BANCSHARES INC. CLASS A
CARS CARS.COM INC.
BRT BRT APARTMENTS
SNBR SLEEP NUMBER CORPORATION
MBIN MERCHANTS BANCORP
PMTS CPI CARD GROUP
LILA LIBERTY LATIN AMERICA A
COLD AMERICOLD REALTY TRUST
BBDC BARINGS BDC INC.
UTGN UTG
RPAY REPAY HOLDINGS (A)
XRX XEROX HOLDINGS CORPORATION
VLA ARBOR METALS
ONEW ONEWATER MARINE
MTCH MATCH GROUP INC.
PRG PROG HOLDINGS
MINM INC.
CIVI MINIM
UDMY INC.
OGN CIVITAS RESOURCES INC
OPAL UDEMY INC
PRME ORGANON & CO
VFC OPAL FUELS INC
PHIN PRIME MEDICINE INC
NCDL VF CORPORATION
FIP PHINIA INC
FG NUVEEN CHURCHILL DIRECT LENDING CORP
HCWB FTAI INFRASTRUCTURE INC
NEO F AND G ANNUITIES AND LIFE
INC.
HCW BIOLOGICS INC
NEO CORPORATE PUBLIC COMPANY LIMITED
America’s Car-Mart, Inc. Completes $216 Million Term Securitization
America’s Car-Mart, Inc. Completes $216 Million Term Securitization ROGERS, Ark., May 30, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), announced today that it has completed a term securitization transaction involving the issuance of $216 million in principal amount of asset-backed notes with an overall weighted average coupon of 6.27%. ACM Auto Trust 2025-2 issued $165.18 million of Class A Notes and $50.82 million of Class B Notes. The Class A Notes have a coupon rate of 5.55% and the Class B Notes have a coupon rate of 7.25%. ...
BRT Apartments Corp: 1 director
A director at BRT Apartments Corp bought 19,360 shares at 15.559USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
America’s Car-Mart Kicks Off Annual Community Fan Drive
America’s Car-Mart Kicks Off Annual Community Fan Drive For more information, contact ROGERS, Ark., May 27, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (Nasdaq: CRMT) announced its annual Community Fan Drive, a company tradition conducted every May and June. For over 25 years, Car-Mart has rallied its customers, associates, and partners to collect fans that are then donated to local charities chosen by each dealership. “Summer means higher temperatures, and it will be difficult for some people to stay cool and comfortable. Every fan can make a big difference in circulating th...
- Jonathan Moreland
TRS TRIMAS CORPORATION
PLUG PLUG POWER INC.
PENN PENN NATIONAL GAMING INC.
PEB PEBBLEBROOK HOTEL TRUST
MMLP MARTIN MIDSTREAM PARTNERS L.P.
JRVR JAMES RIVER GROUP HOLDINGS LTD
GLP GLOBAL PARTNERS LP
PATK PATRICK INDUSTRIES INC.
NEWT NEWTEK BUSINESS SERVICES INC.
RLMD RELMADA THERAPEUTICS
ELY CALLAWAY GOLF COMPANY
FLWS 1-800-FLOWERS.COM CL A
GBLI GLOBAL INDEMNITY PLC
SNDX SYNDAX PHARMACEUTICALS
HAIN THE HAIN CELESTIAL GROUP
NHF INC.
BRT NEXPOINT CREDIT STRATEGIES FUN
OCSL BRT APARTMENTS
MPB OAKTREE SPECIALTY LENDING CORPORATION
FGBI MID PENN BANCORP INC.
MIDD FIRST GUARANTY BANCSHARES
ENR THE MIDDLEBY CORPORATION
AVTR EDGEWELL PERSONAL CARE COMPANY
ZYME AVANTOR
VLA INC.
ONEW ZYMEWORKS INC.
ADV ARBOR METALS
DLHC ONEWATER MARINE
CVRX ADVANTAGE SOLUTIONS INC (A)
PFBX DALEIGH HOLDINGS CORP
TCRX CVRX
STGW INC.
OPAL PEOPLES FINANCIAL CORP. (MISSISSIPPI)
PRME FIRST EAGLE ALTERNATIVE CAPITAL BDC INC
STRW STAGWELL INC
PHIN OPAL FUELS INC
SRBK PRIME MEDICINE INC
SDHC STRAWBERRY FIELDS REIT INC.
FIP PHINIA INC
SUNS SR BANCORP INC
EVM SMITH DOUGLAS HOMES CORP
TXO FTAI INFRASTRUCTURE INC
GF SUNRISE REALTY TRUST
FG EATON VANCE INSD CALIF MUN BD FD
GREE MORNINGSTAR PARTNERS
HCWB L.P.
IAE THE NEW GERMANY FUND
FINS INC.
F AND G ANNUITIES AND LIFE
INC.
GREENIDGE GENERATION HLDGS INC
HCW BIOLOGICS INC
ING ASIA PACIFIC HIGH DIVIDEND EQUITY INCOME FUND
ANGEL OAK FINANCIAL STRATEGIES INCOME TERM TRUST
- Jonathan Moreland
TCBI TEXAS CAPITAL BANCSHARES INC.
PEB PEBBLEBROOK HOTEL TRUST
LTRX LANTRONIX INC.
EXP EAGLE MATERIALS INC.
HAIN THE HAIN CELESTIAL GROUP
CLF INC.
BRT CLIFFS NATURAL RESOURCES INC.
FGBI BRT APARTMENTS
VLA FIRST GUARANTY BANCSHARES
ADV ARBOR METALS
PHIN ADVANTAGE SOLUTIONS INC (A)
FIP PHINIA INC
FTAI INFRASTRUCTURE INC
Acrivon Therapeutics Reports First Quarter 2025 Financial Results and ...
Acrivon Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Corporate R&D event highlighted positive ACR-368 data in endometrial cancer patients who had all received prior anti-PD-1 and platinum-based chemotherapy Confirmed overall response rate (cORR) of 35% and median duration of response (mDOR) >5.6 months (not yet reached) observed in OncoSignature-positive (BM+) patients, a majority of whom were refractory to last prior therapy, and cORR of 50% and mDOR >10 months (not yet reached) for BM+ patients who had relapsed on last prior therapy Three dose escala...
America’s Car-Mart, Inc. Announces Chief Financial Officer Transition
America’s Car-Mart, Inc. Announces Chief Financial Officer Transition Jonathan Collins named Chief Financial Officer, effective May 12, 2025, succeeding Vickie Judy who will transition to Chief Accounting Officer ROGERS, Ark., May 08, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (NASDAQ: CRMT) (“we,” “Car-Mart” or the “Company”), today announced that Jonathan Collins will assume the role of Chief Financial Officer (CFO) effective May 12, 2025. He will succeed Vickie Judy, who will transition to the position of Chief Accounting Officer (CAO). This transition is part of the Company’s...
BRT Apartments Corp. Files First Quarter 2025 Financial Statements
BRT Apartments Corp. Files First Quarter 2025 Financial Statements GREAT NECK, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE:BRT), a real estate investment trust, announced today that it has filed its quarterly report on Form 10-Q for the quarter ended March 31, 2025 with the Securities and Exchange Commission. The financial statements and can be accessed on the Company’s investor relations under the caption “Financials – Quarterly Results.” BRT is a real estate investment trust that owns, operates and, to a lesser extent, holds interests in joint ventures that own ...
- Jonathan Moreland
DHIL DIAMOND HILL INVESTMENT GROUP
MTX MINERALS TECHNOLOGIES INC.
MTDR MATADOR RESOURCES COMPANY
MMLP MARTIN MIDSTREAM PARTNERS L.P.
CBRL CRACKER BARREL OLD COUNTRY STORE INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MBIN MERCHANTS BANCORP
NWPP NEW PEOPLES BANKSHARES INC.
MCFT MASTERCRAFT BOAT HOLDINGS
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SCKT SOCKET MOBILE INC
ACRV ACRIVON THERAPEUTICS INC
OBIO ORCHESTRA BIOMED HOLDINGS INC
CVI CVR ENERGY
PHIN INC.
DMA PHINIA INC
EVM DESTRA MULTI ALTERNATIVE FUND
GF EATON VANCE INSD CALIF MUN BD FD
ECF THE NEW GERMANY FUND
INC.
ELLSWORTH FUND LTD
Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong...
Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025 Presentation to highlight how AP3 Generative Phosphoproteomic analyses uncover how ACR-2316 induces mitotic and replicative tumor cell death, and the mechanisms underlying its superior potency observed preclinically Phase 1 trial of ACR-2316 ahead of schedule with three dose-escalation cohorts completed; solid tumor shrinkage already observed at dose level three, well below the projected recommended P...
Acrivon Therapeutics Appoints World-Renowned Oncology Key Opinion Lead...
Acrivon Therapeutics Appoints World-Renowned Oncology Key Opinion Leader and Clinical Investigator Mansoor Raza Mirza, M.D., as Chief Medical Officer Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials through global regulatory approvals, and establishing new standards of care in gynecological oncology over the past decades Will lead all clinical development -- including the ongoing ACR-368 Phase 2b registrational-intent trial in endometrial cancer towards regulatory submission and potential approval, and the ongoing...
Acrivon Therapeutics Provides Program Updates and Fourth Quarter and F...
Acrivon Therapeutics Provides Program Updates and Fourth Quarter and Full Year 2024 Financial Results Generative Phosphoproteomics AP3 platform designed to enable streamlined, rational drug discovery, with proprietary, proteome-wide SAR delivering desirable pathway effects R&D event highlighted positive ACR-368 endometrial cancer data in OncoSignature-positive (BM+) patients with heavily pretreated aggressive tumors, and who had all progressed on prior anti-PD-1 and chemotherapy, with 35% confirmed overall response rate (cORR), which is >2-fold higher than last prior line of therapy (15%) ...
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platfo...
Acrivon Therapeutics to Host Corporate R&D Event to Provide AP3 Platform Capabilities and Clinical ACR-368 and ACR-2316 Program Updates Event to be held via webcast on March 25, 2025 at 4:00 p.m. ET To highlight differentiated drug discovery capabilities with its Generative Phosphoproteomics AP3 platform and program updates from the Phase 2b study of ACR-368 and Phase 1 study of ACR-2316 WATERTOWN, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its Acrivon Pr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.